miR-143-3p
Differentially expressed MicroRNAs in pituitary neuroendocrine tumor tissues have low abundance in plasma minimizing their role as biomarkers. Plasma miR-143-3p decreases in patients with FSH/LH+ adenoma indicated successful surgery, but its application for evaluating tumor recurrence needs further investigation 1).
1)
Németh K, Darvasi O, Likó I, Szücs N, Czirják S, Reiniger L, Szabó B, Krokker
L, Pállinger É, Igaz P, Patócs A, Butz H. Comprehensive analysis of circulating
microRNAs in plasma of patients with pituitary neuroendocrine tumors. J Clin Endocrinol Metab.
2019 May 21. pii: jc.2018-02479. doi: 10.1210/jc.2018-02479. [Epub ahead of
print] PubMed PMID: 31112271.